Deborah Birx's Net Worth

$1.73 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is Deborah Birx?

Deborah Birx has an estimated net worth of $1.73 Million. This is based on reported shares across multiple companies, which include Innoviva, Inc., and Armata Pharmaceuticals, Inc..

SEC CIK

Deborah Birx's CIK is 0001849673

Past Insider Trading and Trends

2023 was Deborah Birx's most active year for acquiring shares with 4 total transactions. Deborah Birx's most active month to acquire stocks was the month of February. 2024 saw Deborah Birx paying a total of $0.00 for 300,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Innoviva, Inc. (INVA) Snapshot price: $18.7201

Investor

Deborah Birx owns 58,984 units of Common Stock which is worth $1,104,186.38. From 2021 to 2023 Deborah Birx acquired a total of 48,236 shares in Innoviva, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+38.82%
16.5K
—
—
58.98K
May 22
Form 4
+42.38%
12.65K
—
—
42.49K
Apr 25
Form 4
+141.44%
17.48K
—
—
29.84K
May 14
Form 4
+15.00%
1.61K
—
—
12.36K
Mar 29
Form 4
—
0
—
—
0
Mar 22
Form 3
—
0
—
—
0
No matching records found

Armata Pharmaceuticals, Inc. (ARMP) Snapshot price: $2.4

Chief Executive Officer

Deborah Birx owns 260,000 units of Common Stock which is worth $624,000.00. In the year 2023 Deborah Birx acquired a total of 260,000 shares in Armata Pharmaceuticals, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+30.00%
60K
—
—
260K
Mar 14
Form 4
∞
200K
—
—
200K
Dec 21
Form 3
—
0
—
—
0
No matching records found